TME Pharma N.V. (EPA:ALTME)
France flag France · Delayed Price · Currency is EUR
0.0640
-0.0004 (-0.62%)
Apr 25, 2025, 10:21 AM CET

TME Pharma Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2014 - 2018
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Net Income
-6.33-6.74-15.13-14.45-10.41-0.86
Upgrade
Depreciation & Amortization
0.130.140.090.070.060.05
Upgrade
Other Amortization
000.120.050.12-
Upgrade
Stock-Based Compensation
0.410.40.590.480.160.11
Upgrade
Other Operating Activities
0.731.112.911.084.47-3.21
Upgrade
Change in Accounts Payable
-0.02-0.79-0.580.420.39-0.36
Upgrade
Change in Other Net Operating Assets
0.090.24-0.14-0.01-0.03-0.01
Upgrade
Operating Cash Flow
-4.98-5.64-12.14-12.38-5.22-4.29
Upgrade
Capital Expenditures
-0-0.02-0.02-0.01-0.04-0.02
Upgrade
Investment in Securities
-0-----
Upgrade
Investing Cash Flow
-0.01-0.02-0.02-0.01-0.04-0.02
Upgrade
Long-Term Debt Issued
-17.434.375.74-
Upgrade
Long-Term Debt Repaid
--1.04-0.06-0.03-0.06-0.03
Upgrade
Net Debt Issued (Repaid)
-2.2-0.047.374.355.69-0.03
Upgrade
Issuance of Common Stock
6.973.170.097.228.81.52
Upgrade
Repurchase of Common Stock
-0-0-0.03-0-0-
Upgrade
Other Financing Activities
-0.090.14-0.15-0.07-0.3-0.1
Upgrade
Financing Cash Flow
4.683.277.2911.514.181.4
Upgrade
Foreign Exchange Rate Adjustments
0-00.060.05--
Upgrade
Net Cash Flow
-0.31-2.39-4.82-0.858.92-2.91
Upgrade
Free Cash Flow
-4.98-5.65-12.16-12.4-5.26-4.3
Upgrade
Free Cash Flow Margin
----37560.61%-15037.14%-2793.51%
Upgrade
Free Cash Flow Per Share
-0.29-1.13-10.34-18.79-16.27-38.55
Upgrade
Cash Interest Paid
0.010.010.01000
Upgrade
Cash Income Tax Paid
0.010.01----
Upgrade
Levered Free Cash Flow
-2.8-3.57-7.35-7.36-4.59-6
Upgrade
Unlevered Free Cash Flow
-2.81-3.57-7.39-7.38-4.64-6
Upgrade
Change in Net Working Capital
-0.160.570.54-0.511.183.59
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.